Unilever antimicrobial composition patent EP3873209A1
Summary
The European Patent Office published patent EP3873209A1 for Unilever IP Holdings B.V. and Unilever Global IP Limited, covering an antimicrobial composition. The patent application (filed under IPC classifications A01N, A61K) includes claims for chemical compositions with antimicrobial properties designated across 36 European states including AL, AT, BE, BG, CH, DE, FR, GB, IT, NL, and others.
What changed
The EPO published patent application EP3873209A1 for an antimicrobial composition developed by Unilever inventors Ajit Agarkhed, Khushbu Agarwal, Amitabha Majumdar, and Mruthyunjaya Swamy Mathapathi. The patent covers compositions classified under A01N 33/08, A01N 31/08, A01N 31/16, A61K 8/34, and A61K 8/41, indicating claims to specific chemical formulations with antimicrobial properties.
Patent publications do not impose compliance obligations on third parties. Companies developing similar antimicrobial products should conduct freedom-to-operate analyses before commercializing competing formulations. The patent provides Unilever exclusive rights in the designated European states for the claimed compositions and methods of use.
Source document (simplified)
AN ANTIMICROBIAL COMPOSITION
Publication EP3873209A1 Kind: A1 Mar 25, 2026
Applicants
Unilever IP Holdings B.V., UNILEVER GLOBAL IP LIMITED
Inventors
AGARKHED, Ajit ,Manohar, AGARWAL, Khushbu, MAJUMDAR, Amitabha, MATHAPATHI, Mruthyunjaya, Swamy
IPC Classifications
A01N 33/08 20060101AFI20200508BHEP A01N 31/08 20060101ALI20200508BHEP A01N 31/16 20060101ALI20200508BHEP A01P 1/00 20060101ALI20200508BHEP A61K 8/34 20060101ALI20200508BHEP A61K 8/41 20060101ALI20200508BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.